BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27786426)

  • 1. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia.
    Kingston REF; Marel C; Mills KL
    Drug Alcohol Rev; 2017 Jul; 36(4):527-539. PubMed ID: 27786426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point Prevalence and Patterns of Mental Health Comorbidity Among People Accessing Australia's First Older Adult-Specific Alcohol and Other Drug Treatment Service.
    Bright S; Walsh K; Williams C
    J Dual Diagn; 2018; 14(1):70-75. PubMed ID: 29023223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of comorbidity: major mental illness and problematic substance use.
    Siegfried N
    Aust N Z J Psychiatry; 1998 Oct; 32(5):707-17. PubMed ID: 9805595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
    Havassy BE; Alvidrez J; Owen KK
    Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis.
    Baranyi G; Fazel S; Langerfeldt SD; Mundt AP
    Lancet Public Health; 2022 Jun; 7(6):e557-e568. PubMed ID: 35660217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of co-occurring alcohol and other drug use in an Australian older adult mental health service.
    Searby A; Maude P; McGrath I
    Int J Ment Health Nurs; 2016 Apr; 25(2):151-8. PubMed ID: 26834037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system.
    Rush B; Koegl CJ
    Can J Psychiatry; 2008 Dec; 53(12):810-21. PubMed ID: 19087479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being.
    Burns L; Teesson M
    Drug Alcohol Depend; 2002 Dec; 68(3):299-307. PubMed ID: 12393224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up.
    Fridell M; Bäckström M; Hesse M; Krantz P; Perrin S; Nyhlén A
    BMC Psychiatry; 2019 May; 19(1):150. PubMed ID: 31092225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
    Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
    Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring integrated treatment for people with mental health and substance use problems.
    Hamilton I
    Nurs Times; 2010 Mar 23-29; 106(11):12-5. PubMed ID: 20391836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting views and experiences of health professionals on the management of comorbid substance misuse and mental disorders.
    Kavanagh DJ; Greenaway L; Jenner L; Saunders JB; White A; Sorban J; Hamilton G
    Aust N Z J Psychiatry; 2000 Apr; 34(2):279-89. PubMed ID: 10789533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity between substance use disorders and psychiatric conditions.
    Schuckit MA
    Addiction; 2006 Sep; 101 Suppl 1():76-88. PubMed ID: 16930163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.
    Watkins KE; Hunter SB; Wenzel SL; Tu W; Paddock SM; Griffin A; Ebener P
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):749-64. PubMed ID: 15624547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.